Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 310 (RNA5SP310) is classified as a processed pseudogene in the human genome, identifiable by the absence of introns and poly(A) tail signatures, with high sequence similarity to functional 5S rRNA genes. Pseudogenes like RNA5SP310 arise from retrotransposed or duplicated gene sequences that have lost the ability to encode functional products through mutation or regulatory changes. Most pseudogenes, including 5S ribosomal pseudogenes, do not have a known direct function; however, growing evidence suggests that in some contexts, pseudogenes may participate in gene expression regulation (e.g., as competitive endogenous RNAs or long non-coding RNAs). RNA5SP310 is not known to be involved in ribosome structure or function, nor is it a validated therapeutic or diagnostic target. Key distinguishing features: - RNA5SP310 is not an active ribosomal RNA but rather a non-coding genomic element resembling 5S rRNA sequences. - It is classified as a "processed pseudogene," typically integrated far from its parental gene and lacking functionality. - No coding or regulatory role is demonstrated for RNA5SP310 in disease or therapy. Summary judgment: RNA5SP310 is a processed pseudogene, with no current evidence linking it to disease mechanisms or therapeutic targeting. It serves primarily as a genomic reference of the 5S rRNA gene family and has biological but not clinical or pharmacological significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 310 (RNA5SP310).